Cargando…

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab

Detalles Bibliográficos
Autores principales:	Yoo, Dae San, Kim, Jong Hoon, Kim, Soo-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965308/ https://www.ncbi.nlm.nih.gov/pubmed/31970283 http://dx.doi.org/10.1016/j.jdcr.2019.10.017

Ejemplares similares

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Nail changes in female pemphigus vulgaris patients on immunosuppressive therapy()
por: El-Komy, M.M., et al.
Publicado: (2015)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
por: Song, Ahreum, et al.
Publicado: (2022)

Transition from Pemphigus Foliaceus to Pemphigus Vulgaris: Case Report with Literature Review
por: Park, Sang Gun, et al.
Publicado: (2006)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Anterior Scleritis in a Patient of Pemphigus Vulgaris while on Immunosuppressive Treatment
por: Dube, Mihika, et al.
Publicado: (2019)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
por: Chotaliya, Kiran K., et al.
Publicado: (2015)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
por: Khatib, Mohamad Y., et al.
Publicado: (2020)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
por: Corral, Isabela Soubhia, et al.
Publicado: (2013)

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
por: Chen, D.M., et al.
Publicado: (2019)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
por: Dolenc‐Voljč, Mateja, et al.
Publicado: (2022)

ACTH Therapy in Pemphigus Vulgaris
por: Chakraborty, A. N., et al.
Publicado: (1953)

Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child
por: De Felici Del Giudice, Maria Beatrice, et al.
Publicado: (2023)

Biosimilars in Pemphigus Vulgaris
por: Patil, Sharmila, et al.
Publicado: (2014)

Management of Pemphigus Vulgaris
por: Cholera, Mimansa, et al.
Publicado: (2016)

The Genetics of Pemphigus Vulgaris
por: Vodo, Dan, et al.
Publicado: (2018)

Oral Pemphigus Vulgaris
por: Subadra, K, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
por: Fenizia, Claudio, et al.
Publicado: (2023)

B Cell Profiling in Patients with Pemphigus Vulgaris
por: Abrikosova, V. A., et al.
Publicado: (2023)

Sustained CD19(+)CD27(+) Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Subtype transition from pemphigus vulgaris to pemphigus foliaceus
por: Gilkey, Ty, et al.
Publicado: (2022)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
por: Müller, Ralf, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_joe2e7bhs39gj14md3j1oa6un9